Other
Common Stock, Shares, Outstanding
Moderna Common Stock, Shares, Outstanding increased by 0.8% to $397M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 2.6%, from $387M to $397M. Over 5 years (FY 2020 to FY 2025), Common Stock, Shares, Outstanding shows relatively stable performance with a -0.3% CAGR.
Analysis
StatementBalance Sheet Statement
SectionOther
First reportedQ4 2018
Last reportedQ1 2026May 1, 2026
Metric ID:
other_common_stock_shares_outstandingHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $403M | $405M | $403M | $400M | $392M | $387M | $385M | $384M | $381M | $381M | $382M | $383M | $384M | $385M | $386M | $387M | $389M | $391M | $394M | $397M |
| QoQ Change | — | +0.5% | -0.5% | -0.7% | -2.0% | -1.3% | -0.5% | -0.3% | -0.8% | +0.0% | +0.3% | +0.3% | +0.3% | +0.3% | +0.3% | +0.3% | +0.5% | +0.5% | +0.8% | +0.8% |
| YoY Change | — | — | — | — | -2.7% | -4.4% | -4.5% | -4.0% | -2.8% | -1.6% | -0.8% | -0.3% | +0.8% | +1.0% | +1.0% | +1.0% | +1.3% | +1.6% | +2.1% | +2.6% |
Range$381M – $405M
CAGR-0.3%
Avg YoY Growth-0.6%
Median YoY Growth+0.3%
Current Streak11 quarters growth
Common Stock, Shares, Outstanding at Other Companies
Frequently Asked Questions
- What is Moderna's common stock, shares, outstanding?
- Moderna (MRNA) reported common stock, shares, outstanding of $397M in Q1 2026.
- How has Moderna's common stock, shares, outstanding changed year-over-year?
- Moderna's common stock, shares, outstanding increased by 2.6% year-over-year, from $387M to $397M.
- What is the long-term trend for Moderna's common stock, shares, outstanding?
- Over 5 years (2020 to 2025), Moderna's common stock, shares, outstanding has grown at a -0.3% compound annual growth rate (CAGR), from $399M to $394M.